Member Exclusive

Could a novel drug target improve survival rates for patients with pulmonary hypertension?

Researchers have identified the gene FOXM1 as a promising target for the treatment of pulmonary hypertension, hoping to design drugs to reverse the vascular remodeling seen in these patients.

Go to the profile of Jasmine Harris
May 01, 2018

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.